MAPT and Alzheimer disease: This dysfunction was also associated with certain biomarkers, like the apolipoprotein E (APOE) ε4 allele, tau protein, and amyloid-β deposits, which were implicated in adverse health outcomes such as cardiovascular diseases, and Alzheimer’s disease [38,39].